Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.23 USD | +1.60% |
|
+4.71% | +16.49% |
Jul. 15 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
Jul. 15 | ANI Pharmaceuticals, Inc. Announces the FDA Approval and Launch of L-Glutamine Oral Powder | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.49% | 1.23B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Transcript : Alimera Sciences, Inc., ANI Pharmaceuticals, Inc. - M&A Call